1. Zhang, Jinyu, Wei, Yunhai, Min, Jie, Cao, Guoliang, Shen, Hua. 2019. Knockdown of RAP2A gene expression suppresses cisplatin resistance in gastric cancer cells. In Oncology letters, 19, 350-358. doi:10.3892/ol.2019.11086. https://pubmed.ncbi.nlm.nih.gov/31897147/
2. Wu, Jin-Xia, Zhang, Ding-Guo, Zheng, Jun-Nian, Pei, Dong-Sheng. 2015. Rap2a is a novel target gene of p53 and regulates cancer cell migration and invasion. In Cellular signalling, 27, 1198-207. doi:10.1016/j.cellsig.2015.02.026. https://pubmed.ncbi.nlm.nih.gov/25728512/
3. Valentine, Joseph M, Ahmadian, Maryam, Keinan, Omer, Rydén, Mikael, Saltiel, Alan R. . β3-Adrenergic receptor downregulation leads to adipocyte catecholamine resistance in obesity. In The Journal of clinical investigation, 132, . doi:10.1172/JCI153357. https://pubmed.ncbi.nlm.nih.gov/34847077/
4. Carvalho, Brener C, Oliveira, Leonardo C, Rocha, Carolina D, Ghosh, Sankar, Silva, Aristóbolo M. 2019. Both knock-down and overexpression of Rap2a small GTPase in macrophages result in impairment of NF-κB activity and inflammatory gene expression. In Molecular immunology, 109, 27-37. doi:10.1016/j.molimm.2019.02.015. https://pubmed.ncbi.nlm.nih.gov/30851634/